Pentax Canada Inc
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1919-01-01
- Employees
- 251
- Market Cap
- -
Clinical Trials
13
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Extra Wide Field of View Lens Study
- Conditions
- Colonic Polyp
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Pentax Medical
- Target Recruit Count
- 60
- Registration Number
- NCT06483503
- Locations
- 🇩🇪
RKM 740 Interdisciplinary Care Clinic - Gastroenterology, Düsseldorf, Germany
C2 Esophageal Squamous Epithelium Dysplasia
- Conditions
- Esophageal Squamous Epithelium Dysplasia
- First Posted Date
- 2022-04-27
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Pentax Medical
- Target Recruit Count
- 129
- Registration Number
- NCT05349240
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China
🇨🇳The First Bethune Hospital of Jilin University, Changchun, China
🇨🇳Changzhi People's Hospital, Changzhi, China
C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study.
- Conditions
- Barrett Esophagus
- First Posted Date
- 2017-10-17
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Pentax Medical
- Target Recruit Count
- 30
- Registration Number
- NCT03311451
- Locations
- 🇳🇱
AMC Medical Research B.V., Amsterdam, Netherlands
🇳🇱UMC Groningen, Groningen, Netherlands
🇳🇱St. Antonius Hospital, Nieuwegein, Netherlands
Evaluation of Safety and Dose Response Using C2 CryoBalloon™ Swipe Ablation System for Barrett's Esophagus
- Conditions
- Barrett Esophagus
- First Posted Date
- 2017-03-31
- Last Posted Date
- 2022-04-22
- Lead Sponsor
- Pentax Medical
- Target Recruit Count
- 24
- Registration Number
- NCT03097666
- Locations
- 🇳🇱
AMC Medical Research B.V., Amsterdam, Netherlands
🇳🇱St. Antonius Hospital Nieuwegein, Amsterdam, Netherlands
🇳🇱Catharina Ziekenhuis te Eindhoven, Eindhoven, Netherlands
Clinical Study to Evaluate CryoBalloon™ Ablation System in Patients Undergoing Esophagectomy
- Conditions
- Esophageal Cancer
- First Posted Date
- 2016-04-06
- Last Posted Date
- 2022-04-28
- Lead Sponsor
- Pentax Medical
- Target Recruit Count
- 3
- Registration Number
- NCT02729727
- Locations
- 🇳🇱
Academic Medical Centre Amsterdam, Amsterdam, North Holland, Netherlands
- Prev
- 1
- 2
- 3
- Next
News
WVU Cancer Institute Pioneers Esophageal Cancer Prevention with Cryoballoon Device
WVU Cancer Institute is the first to commercially use the FDA-approved 180° C2 Cryoballoon for Barrett's esophagus treatment, a precancerous condition.